Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case-control study, Spain, October 2023 to March 2025.
Saved in:
| Title: | Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case-control study, Spain, October 2023 to March 2025. |
|---|---|
| Authors: | Núñez O; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain., Juaneda J; Directorate-General for Public Health, Valencia, Valencian Community, Spain., Martinez-Marcos M; Agència de Salut Pública de Catalunya (ASPCAT), Barcelona, Catalonia, Spain., Muñoz Platón E; Directorate-General of Public Health, Toledo, Castilla-La Mancha, Spain., Rivas Wagner E; Directorate-General of Public Health, Canary Islands Health Service, Santa Cruz de Tenerife, Canary Islands, Spain., Santiago-Pérez MI; Directorate-General of Public Health, Department of Health, Santiago de Compostela, Galicia, Spain., Álvarez Río V; Directorate-General of Public Health, Department of Health, Valladolid, Castilla y León, Spain., Zornoza Moreno M; Directorate-General of Public Health and Addictions, Murcia, Region of Murcia, Spain., Fernández Ibáñez A; Directorate-General of Public and Mental Health, Oviedo, Asturias, Spain., Perez Suarez G; Directorate-General of Public Health, Zaragoza, Aragón, Spain., Loroño Ortiz G; Department of Health, Vitoria-Gasteiz, Basque Country, Spain., Egüés N; Instituto de Salud Pública y Laboral de Navarra - IdiSNA, Pamplona, Navarra, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Berradre Sáenz B; Directorate-General of Public Health, Logroño, La Rioja, Spain., Cuesta Franco MLÁ; Directorate-General of Public Health, Mérida, Extremadura, Spain., Casado Cobo S; Directorate-General of Public Health, Santander, Cantabria, Spain., Domínguez Padilla M; University Hospital of Ceuta, Ceuta, Spain., Castrillejo D; Directorate-General of Public Health, Melilla, Spain., Míguez Santiyán A; Directorate-General for Public Health, Valencia, Valencian Community, Spain., Basile L; Agència de Salut Pública de Catalunya (ASPCAT), Barcelona, Catalonia, Spain., Rafael de la Cruz López MÁ; Directorate-General of Public Health, Toledo, Castilla-La Mancha, Spain., Sanabria Curbelo D; Directorate-General of Public Health, Canary Islands Health Service, Santa Cruz de Tenerife, Canary Islands, Spain., Pérez-Martínez O; Directorate-General of Public Health, Department of Health, Santiago de Compostela, Galicia, Spain., Rodríguez Recio MJ; Directorate-General of Public Health, Department of Health, Valladolid, Castilla y León, Spain., Duro Gómez L; Directorate-General of Public Health and Addictions, Murcia, Region of Murcia, Spain., Alonso Vigil MDP; Directorate-General of Public and Mental Health, Oviedo, Asturias, Spain., Mendez Diaz M; Directorate-General of Public Health, Zaragoza, Aragón, Spain., Sancho R; Department of Health, Vitoria-Gasteiz, Basque Country, Spain., Castilla J; Instituto de Salud Pública y Laboral de Navarra - IdiSNA, Pamplona, Navarra, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Ibáñez Pérez AC; Directorate-General of Public Health, Logroño, La Rioja, Spain., Batalla Rebollo N; Directorate-General of Public Health, Mérida, Extremadura, Spain., Sánchez Piorno L; Directorate-General of Public Health, Santander, Cantabria, Spain., López Berrios N; Public Health Department, Ceuta, Spain., Lamas J; University Hospital of Melilla, Melilla, Spain., Olmedo C; Vaccines Division, Directorate-General of Public Health, Ministry of Health, Madrid, Spain., Monge S; These authors contributed equally to the work and share last authorship.; Consortium for Biomedical Research on Infectious Diseases (CIBERINFEC), Madrid, Spain.; National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain., Pastor-Barriuso R; These authors contributed equally to the work and share last authorship.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain. |
| Corporate Authors: | Nirsevimab Effectiveness Study Collaborators; The members of the group are listed under collaborators. |
| Source: | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2026 Mar; Vol. 31 (9). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41788029 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case-control study, Spain, October 2023 to March 2025. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Núñez+O%22">Núñez O</searchLink>; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Juaneda+J%22">Juaneda J</searchLink>; Directorate-General for Public Health, Valencia, Valencian Community, Spain.<br /><searchLink fieldCode="AU" term="%22Martinez-Marcos+M%22">Martinez-Marcos M</searchLink>; Agència de Salut Pública de Catalunya (ASPCAT), Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Muñoz+Platón+E%22">Muñoz Platón E</searchLink>; Directorate-General of Public Health, Toledo, Castilla-La Mancha, Spain.<br /><searchLink fieldCode="AU" term="%22Rivas+Wagner+E%22">Rivas Wagner E</searchLink>; Directorate-General of Public Health, Canary Islands Health Service, Santa Cruz de Tenerife, Canary Islands, Spain.<br /><searchLink fieldCode="AU" term="%22Santiago-Pérez+MI%22">Santiago-Pérez MI</searchLink>; Directorate-General of Public Health, Department of Health, Santiago de Compostela, Galicia, Spain.<br /><searchLink fieldCode="AU" term="%22Álvarez+Río+V%22">Álvarez Río V</searchLink>; Directorate-General of Public Health, Department of Health, Valladolid, Castilla y León, Spain.<br /><searchLink fieldCode="AU" term="%22Zornoza+Moreno+M%22">Zornoza Moreno M</searchLink>; Directorate-General of Public Health and Addictions, Murcia, Region of Murcia, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández+Ibáñez+A%22">Fernández Ibáñez A</searchLink>; Directorate-General of Public and Mental Health, Oviedo, Asturias, Spain.<br /><searchLink fieldCode="AU" term="%22Perez+Suarez+G%22">Perez Suarez G</searchLink>; Directorate-General of Public Health, Zaragoza, Aragón, Spain.<br /><searchLink fieldCode="AU" term="%22Loroño+Ortiz+G%22">Loroño Ortiz G</searchLink>; Department of Health, Vitoria-Gasteiz, Basque Country, Spain.<br /><searchLink fieldCode="AU" term="%22Egüés+N%22">Egüés N</searchLink>; Instituto de Salud Pública y Laboral de Navarra - IdiSNA, Pamplona, Navarra, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Berradre+Sáenz+B%22">Berradre Sáenz B</searchLink>; Directorate-General of Public Health, Logroño, La Rioja, Spain.<br /><searchLink fieldCode="AU" term="%22Cuesta+Franco+MLÁ%22">Cuesta Franco MLÁ</searchLink>; Directorate-General of Public Health, Mérida, Extremadura, Spain.<br /><searchLink fieldCode="AU" term="%22Casado+Cobo+S%22">Casado Cobo S</searchLink>; Directorate-General of Public Health, Santander, Cantabria, Spain.<br /><searchLink fieldCode="AU" term="%22Domínguez+Padilla+M%22">Domínguez Padilla M</searchLink>; University Hospital of Ceuta, Ceuta, Spain.<br /><searchLink fieldCode="AU" term="%22Castrillejo+D%22">Castrillejo D</searchLink>; Directorate-General of Public Health, Melilla, Spain.<br /><searchLink fieldCode="AU" term="%22Míguez+Santiyán+A%22">Míguez Santiyán A</searchLink>; Directorate-General for Public Health, Valencia, Valencian Community, Spain.<br /><searchLink fieldCode="AU" term="%22Basile+L%22">Basile L</searchLink>; Agència de Salut Pública de Catalunya (ASPCAT), Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Rafael+de+la+Cruz+López+MÁ%22">Rafael de la Cruz López MÁ</searchLink>; Directorate-General of Public Health, Toledo, Castilla-La Mancha, Spain.<br /><searchLink fieldCode="AU" term="%22Sanabria+Curbelo+D%22">Sanabria Curbelo D</searchLink>; Directorate-General of Public Health, Canary Islands Health Service, Santa Cruz de Tenerife, Canary Islands, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-Martínez+O%22">Pérez-Martínez O</searchLink>; Directorate-General of Public Health, Department of Health, Santiago de Compostela, Galicia, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez+Recio+MJ%22">Rodríguez Recio MJ</searchLink>; Directorate-General of Public Health, Department of Health, Valladolid, Castilla y León, Spain.<br /><searchLink fieldCode="AU" term="%22Duro+Gómez+L%22">Duro Gómez L</searchLink>; Directorate-General of Public Health and Addictions, Murcia, Region of Murcia, Spain.<br /><searchLink fieldCode="AU" term="%22Alonso+Vigil+MDP%22">Alonso Vigil MDP</searchLink>; Directorate-General of Public and Mental Health, Oviedo, Asturias, Spain.<br /><searchLink fieldCode="AU" term="%22Mendez+Diaz+M%22">Mendez Diaz M</searchLink>; Directorate-General of Public Health, Zaragoza, Aragón, Spain.<br /><searchLink fieldCode="AU" term="%22Sancho+R%22">Sancho R</searchLink>; Department of Health, Vitoria-Gasteiz, Basque Country, Spain.<br /><searchLink fieldCode="AU" term="%22Castilla+J%22">Castilla J</searchLink>; Instituto de Salud Pública y Laboral de Navarra - IdiSNA, Pamplona, Navarra, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ibáñez+Pérez+AC%22">Ibáñez Pérez AC</searchLink>; Directorate-General of Public Health, Logroño, La Rioja, Spain.<br /><searchLink fieldCode="AU" term="%22Batalla+Rebollo+N%22">Batalla Rebollo N</searchLink>; Directorate-General of Public Health, Mérida, Extremadura, Spain.<br /><searchLink fieldCode="AU" term="%22Sánchez+Piorno+L%22">Sánchez Piorno L</searchLink>; Directorate-General of Public Health, Santander, Cantabria, Spain.<br /><searchLink fieldCode="AU" term="%22López+Berrios+N%22">López Berrios N</searchLink>; Public Health Department, Ceuta, Spain.<br /><searchLink fieldCode="AU" term="%22Lamas+J%22">Lamas J</searchLink>; University Hospital of Melilla, Melilla, Spain.<br /><searchLink fieldCode="AU" term="%22Olmedo+C%22">Olmedo C</searchLink>; Vaccines Division, Directorate-General of Public Health, Ministry of Health, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Monge+S%22">Monge S</searchLink>; These authors contributed equally to the work and share last authorship.; Consortium for Biomedical Research on Infectious Diseases (CIBERINFEC), Madrid, Spain.; National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pastor-Barriuso+R%22">Pastor-Barriuso R</searchLink>; These authors contributed equally to the work and share last authorship.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Nirsevimab+Effectiveness+Study+Collaborators%22">Nirsevimab Effectiveness Study Collaborators</searchLink>; The members of the group are listed under collaborators. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100887452%22">Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</searchLink> [Euro Surveill] 2026 Mar; Vol. 31 (9). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22European+Centre+for+Disease+Prevention+and+Control+%28ECDC%29%22">European Centre for Disease Prevention and Control (ECDC) </searchLink><i>Country of Publication: </i>Sweden <i>NLM ID: </i>100887452 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1560-7917 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221025496X%22">1025496X </searchLink><i>NLM ISO Abbreviation: </i>Euro Surveill <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41788029 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2807/1560-7917.ES.2026.31.9.2500593 Languages: – Code: eng Text: English Titles: – TitleFull: Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case-control study, Spain, October 2023 to March 2025. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Núñez O – PersonEntity: Name: NameFull: Juaneda J – PersonEntity: Name: NameFull: Martinez-Marcos M – PersonEntity: Name: NameFull: Muñoz Platón E – PersonEntity: Name: NameFull: Rivas Wagner E – PersonEntity: Name: NameFull: Santiago-Pérez MI – PersonEntity: Name: NameFull: Álvarez Río V – PersonEntity: Name: NameFull: Zornoza Moreno M – PersonEntity: Name: NameFull: Fernández Ibáñez A – PersonEntity: Name: NameFull: Perez Suarez G – PersonEntity: Name: NameFull: Loroño Ortiz G – PersonEntity: Name: NameFull: Egüés N – PersonEntity: Name: NameFull: Berradre Sáenz B – PersonEntity: Name: NameFull: Cuesta Franco MLÁ – PersonEntity: Name: NameFull: Casado Cobo S – PersonEntity: Name: NameFull: Domínguez Padilla M – PersonEntity: Name: NameFull: Castrillejo D – PersonEntity: Name: NameFull: Míguez Santiyán A – PersonEntity: Name: NameFull: Basile L – PersonEntity: Name: NameFull: Rafael de la Cruz López MÁ – PersonEntity: Name: NameFull: Sanabria Curbelo D – PersonEntity: Name: NameFull: Pérez-Martínez O – PersonEntity: Name: NameFull: Rodríguez Recio MJ – PersonEntity: Name: NameFull: Duro Gómez L – PersonEntity: Name: NameFull: Alonso Vigil MDP – PersonEntity: Name: NameFull: Mendez Diaz M – PersonEntity: Name: NameFull: Sancho R – PersonEntity: Name: NameFull: Castilla J – PersonEntity: Name: NameFull: Ibáñez Pérez AC – PersonEntity: Name: NameFull: Batalla Rebollo N – PersonEntity: Name: NameFull: Sánchez Piorno L – PersonEntity: Name: NameFull: López Berrios N – PersonEntity: Name: NameFull: Lamas J – PersonEntity: Name: NameFull: Olmedo C – PersonEntity: Name: NameFull: Monge S – PersonEntity: Name: NameFull: Pastor-Barriuso R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1560-7917 Numbering: – Type: volume Value: 31 – Type: issue Value: 9 Titles: – TitleFull: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin Type: main |
| ResultId | 1 |